Vlad Coric Appointed to The Community Foundation for Greater New Haven Board of Directors
Chairman and CEO of Biohaven to serve a seven-year term through 2029.
New Haven, Conn. (March 16, 2023) – The Board of Directors of The Community Foundation for Greater New Haven has announced the appointment of Vlad Coric, MD, CEO of Biohaven, to serve on the Board for a seven-year term (2023-2029). Coric was named by the Greater New Haven Chamber of Commerce, an appointing agency to The Foundation. He succeeds Roxanne Coady who served on the Board since 2016.
“Vlad Coric is a key leader in the industry that is building our community’s future economic base,” said Foundation President and CEO Will Ginsberg. “Vlad’s background and experience is a good complement to the ways The Foundation is prioritizing equitable opportunity and connecting The Foundation to the growth sectors of our local economy. He will add much to the work of The Community Foundation.”
In his over seven years as CEO, Dr. Coric has overseen the dramatic growth of Biohaven from an entrepreneurial start-up into a modern, publicly traded company listed on the New York Stock Exchange. Under his stewardship, Biohaven has focused on discovering, developing and commercializing life-changing therapies that address unmet medical needs. He successfully led the company through its first FDA approval and the launch of Nurtec® ODT (rimegepant; CGRP receptor antagonist) for the acute treatment of migraine, followed by the approval of an expanded indication for Nurtec ODT for the preventive treatment of episodic migraine — becoming the first all-in-one migraine medication for the acute and preventive treatment of migraine. Capitalizing on the extraordinary patient and shareholder value that Biohaven has built with Nurtec ODT and its CGRP franchise, Dr. Coric spearheaded the acquisition of Biohaven by Pfizer in May 2022 for approximately $13 billion in total consideration. He has positioned Biohaven on its new course continuing its growth trajectory, harnessing its proven drug development expertise and broad therapeutic portfolio comprised of early- and late-stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders, with little or no treatment options. These include epilepsy, pain and mood disorders, obsessive compulsive disorder (OCD), spinocerebellar ataxia (SCA) and spinal muscular atrophy (SMA).
“For three generations, the philanthropic efforts of The Community Foundation for Greater New Haven have had an extraordinary imprint in making south central Connecticut a special place for everyone who calls our community home,” says Coric, “I am honored to join the Board and work alongside this diverse and distinguished group of leaders to help advance the programs and support the causes that build upon the Foundation’s legacy of giving.”
Dr. Coric has more than 20 years of drug discovery and clinical development experience at Yale School of Medicine and Bristol-Myers Squibb prior to leading Biohaven. Within the pharmaceutical industry, he has expertise working across therapeutic areas including neuroscience, virology, oncology and immuno-oncology. Since July 2001, Dr. Coric has also continued to serve as an Associate Clinical Professor of Psychiatry at Yale School of Medicine. He previously served as the inpatient chief of the Yale Clinical Neuroscience Research Unit and the director of the Yale Obsessive-Compulsive Disorder Research Clinic. He earned his medical degree from Wake Forest University School of Medicine and was an honors scholar in neurobiology and physiology at the University of Connecticut, where he received his Bachelor of Science degree.
About The Community Foundation for Greater New Haven
The Community Foundation for Greater New Haven’s mission is to inspire, support, inform, listen to and collaborate with the people and organizations of Greater New Haven to build an ever more connected, inclusive, equitable and philanthropic community. Established in 1928 The Foundation is one of the oldest and largest community foundations in the U.S and has been built by donors supporting a broad variety of issues and organizations. As the permanent charitable endowment for 20 towns in Greater New Haven, The Foundation is implementing a 5-year strategic plan to expanding opportunity and equity in our region. Stepping Forward, a $26 million commitment addressing the impact of COVID-19 and advancing racial equity is also in place through 2023. For more information about The Foundation visit www.cfgnh.org or follow @cfgnh on facebook and twitter.
###
